Search Results

There are 13201 results for: content related to: Effect of peginterferon alfa-2a (40 KD ) on cytochrome P 450 isoenzyme activity

  1. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Version of Record online : 5 OCT 2005, DOI: 10.1002/hep.20927

  2. You have free access to this content
    Current and emerging antiviral treatments for hepatitis C infection

    British Journal of Clinical Pharmacology

    Volume 75, Issue 4, April 2013, Pages: 931–943, Joseph S. Doyle, Esther Aspinall, Danny Liew, Alexander J. Thompson and Margaret E. Hellard

    Version of Record online : 15 MAR 2013, DOI: 10.1111/j.1365-2125.2012.04419.x

  3. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22017

  4. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  5. You have free access to this content
    Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: Randomized study of higher doses of peginterferon α-2a and ribavirin

    Hepatology

    Volume 48, Issue 4, October 2008, Pages: 1033–1043, Michael W. Fried, Donald M. Jensen, Maribel Rodriguez-Torres, Lisa M. Nyberg, Adrian M. Di Bisceglie, Timothy R. Morgan, Paul J. Pockros, Amy Lin, Lisa Cupelli, Frank Duff, Ka Wang and David R. Nelson

    Version of Record online : 9 JUN 2008, DOI: 10.1002/hep.22448

  6. You have free access to this content
    Understanding the effect of the HCV polymerase inhibitor mericitabine on early viral kinetics in the phase 2 JUMP-C and PROPEL studies

    British Journal of Clinical Pharmacology

    Volume 78, Issue 3, September 2014, Pages: 533–542, Ya-Chi Chen, Coen Bernaards, Rohit Kulkarni, Sebastian Moreira, Yonghong Zhu, Anna Chan, Ethan Badman, Andrew Ackrill, James Thommes and Patrick F. Smith

    Version of Record online : 21 AUG 2014, DOI: 10.1111/bcp.12369

  7. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  8. You have free access to this content
    Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: A randomized controlled trial

    Hepatology

    Volume 50, Issue 4, October 2009, Pages: 1045–1055, Stuart K. Roberts, Martin D. Weltman, Darrell H. G. Crawford, Geoffrey W. McCaughan, William Sievert, Wendy S. Cheng, William Rawlinson, Paul V. Desmond, Phillipa S. Marks, Motoko Yoshihara, Bishoy Rizkalla, Jean K. DePamphilis, Gregory J. Dore and Chariot Study Group

    Version of Record online : 15 JUN 2009, DOI: 10.1002/hep.23130

  9. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  10. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22644

  11. You have free access to this content
    The pharmacokinetics of peginterferon alfa-2a and ribavirin in African American, Hispanic and Caucasian patients with chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 10, May 2012, Pages: 1209–1220, B. J. Brennan, P. N. Morcos, K. Wang, S. D. Blotner, R. Morrison, C. H. Hagedorn, T. C. Marbury, M. Sulkowski and J. F. Grippo

    Version of Record online : 3 APR 2012, DOI: 10.1111/j.1365-2036.2012.05079.x

  12. You have free access to this content
    Hepatitis C virus: How genetic variability affects pathobiology of disease

    Journal of Gastroenterology and Hepatology

    Volume 26, Issue s1, January 2011, Pages: 83–95, Kazuaki Chayama and C Nelson Hayes

    Version of Record online : 4 JAN 2011, DOI: 10.1111/j.1440-1746.2010.06550.x

  13. You have free access to this content
    Pharmacokinetics and response of obese patients with chronic hepatitis C treated with different doses of PEG-IFN α-2a (40KD) (PEGASYS®)

    British Journal of Clinical Pharmacology

    Volume 67, Issue 3, March 2009, Pages: 280–287, Brian Bressler, Ka Wang, Joseph F. Grippo and E. Jenny Heathcote

    Version of Record online : 20 MAR 2009, DOI: 10.1111/j.1365-2125.2008.03349.x

  14. You have free access to this content
    AASLD Abstracts 1606–1960

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 1019A–1187A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22647

  15. You have free access to this content
    A pharmacokinetic and pharmacodynamic comparison of a novel pegylated recombinant consensus interferon-α variant with peginterferon-α-2a in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 79, Issue 4, April 2015, Pages: 650–659, Li Zheng, Mao Ping Li, Zhong Ping Gou, Ying Wang, Nan Xu, Yong Ming Cai and Hua Luo

    Version of Record online : 23 MAR 2015, DOI: 10.1111/bcp.12528

  16. Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null responders

    Liver International

    Volume 35, Issue 10, October 2015, Pages: 2275–2284, Balazs Fülöp, Michael Biermer, Markus Cornberg, Heiner Wedemeyer, Kerstin Port, Renate Heyne, Stefan Zeuzem, Kai-Henrik Peiffer, Tania Welzel, Adam Herber, Peter Buggisch, Christoph Moser, Sabine Stoll, Ulrich Alshuth and Thomas Berg

    Version of Record online : 20 APR 2015, DOI: 10.1111/liv.12832

  17. OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 120–129, Raffaele Bruno, Giuseppe Cariti, Paola Nasta, Amedeo Capetti, Veronica Ravasio, Massimo Galli, Enzo Raise, Giulio Palmieri, Claudio Iannacone and Massimo Puoti

    Version of Record online : 11 AUG 2014, DOI: 10.1111/liv.12641

  18. You have free access to this content
    Review article: the role of rapid virological response in determining treatment duration for chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1251–1267, F. F. POORDAD

    Version of Record online : 17 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04300.x

  19. You have free access to this content
    Abstracts 624–854

    Hepatology

    Volume 50, Issue S4, 2009, Pages: 600A–705A,

    Version of Record online : 23 SEP 2009, DOI: 10.1002/hep.23303

  20. You have free access to this content
    Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders

    Hepatology

    Volume 50, Issue 6, December 2009, Pages: 1719–1726, Vinod K. Rustgi, William M. Lee, Eric Lawitz, Stuart C. Gordon, Nezam Afdhal, Fred Poordad, Herbert L. Bonkovsky, Leif Bengtsson, Gurudatt Chandorkar, Matthew Harding, Lindsay McNair, Molly Aalyson, John Alam, Robert Kauffman, Shahin Gharakhanian, John G. McHutchison and MErimepodib TRiple cOmbination (METRO) study group

    Version of Record online : 5 AUG 2009, DOI: 10.1002/hep.23204